Characteristic | No. of patients (%) | p value |
---|---|---|
Gender | 0.380 | |
Male: Female | 48 (84.2): 9 (15.8) | |
Age (y) | 0.750 | |
≥ 60: < 60 | 36 (63.2): 21 (36.8) | |
Karnofsky Performance Status | 0.470 | |
80: >80 | 13 (22.8): 44 (77.2) | |
Histopathology | - | |
Squamous cell carcinoma | 28 (49.1) | |
Adenocarcinoma | 20 (35.1) | |
Large cell carcinoma | 3 (5.3) | |
NSCLC, not otherwise specified | 6 (10.5) | |
Clinical stage | 1.000 | |
IIIA: IIIB | 19 (33.3): 38 (66.7) | |
Smoking history | 0.702 | |
No: Yes | 12 (21.1): 45 (78.9) | |
Chemotherapy | 0.301 | |
Concurrent: Sequential | 17 (29.8): 40 (70.2) | |
Primary tumor location | 0.087 | |
Upper: Middle and lower lobe | 25 (43.9): 32 (56.1) |